SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,795.00    100.00 (1.49%)
Bid:
6,790.00
Ask:
6,800.00
Spread: 10.00 (0.147%)
Market Cap: £5.01b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

7 Nov 2008 07:00

RNS Number : 6666H
Spirax-Sarco Engineering PLC
07 November 2008
 



Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Glos. GL53 8ER

News Release

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

Friday 7th November 2008 [embargoed until 7.00 am]

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement based on the four month period to 31st October 2008.

Trading

As expected, we have begun to see some moderation in the pace of growth in demand from our customers, particularly in Continental Europe, although the overall organic sales growth trend in the first half year has broadly continued through October. Despite the Korean Won weakening sharply, currency effects have continued to move in our favour and have added 8% to Group revenues this year, with a larger benefit to operating profit.

Our business is today even more well spread across all geographic regions and across an even wider range of industries and products. We have a large element of replacement sales and the relatively high cost of energy has supported our energy-saving solutions for customers. These factors have historically provided some resilience.

Financial position

We continue to operate with a strong balance sheet. The Group had a net cash balance at 30th June 2008 of £12m, despite having made an initial £11m payment in February for the acquisition of Flexicon. There has been no material change in the financial position of the Group during the period, with net cash balances increasing to £26m at 31st October 2008. The company intends to purchase one million of its own shares to be held in Treasury to meet the requirements of the Group share schemes. The net liability in respect of post-retirement benefits rose to £33m (net of deferred tax) at the half-year and fluctuates in relation to movements in equity and bond markets, which remain volatile. We still expect capital expenditure to be higher than normal this year and in 2009.

Outlook

In our prospects statement in the half-year results announcement made in August, we noted the deteriorating global macro-economic environment, which has been confirmed by more recent GDP and Industrial Production rates and forecasts, and which increases the uncertainty looking forward. However, our business is well spread and generally resilient, and we have a strong balance sheet. We continue to invest for the long term, particularly in developing market areas where economic conditions look more favourable, and are focused on progressively growing our market share. Given continued beneficial exchange rates and no significant deterioration in trading conditions in our markets, we expect to achieve good progress for the year.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535236

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBDGGGGIL
Date   Source Headline
2nd Aug 20238:00 amRNSBoard Appointment
1st Aug 20239:09 amRNSDirector/PDMR Shareholding
27th Jul 20239:30 amRNSChange in Director Details
26th Jun 202310:00 amRNSNotice of Investment Seminar
22nd Jun 20232:03 pmRNSHolding(s) in Company
22nd Jun 20237:00 amRNSKyoto Investment and Partnership Agreement
14th Jun 202310:42 amRNSHolding(s) in Company
9th Jun 20235:45 pmRNSHolding(s) in Company
24th May 20232:46 pmRNSHolding(s) in Company
10th May 20233:23 pmRNSResult of AGM
10th May 20237:00 amRNSAGM Trading Update
16th Mar 20234:22 pmRNSDirector/PDMR Shareholding
16th Mar 20239:00 amRNSDirector/PDMR Shareholding
15th Mar 20234:12 pmRNSDirector/PDMR Shareholding
15th Mar 20239:53 amRNSDirector/PDMR Shareholding
15th Mar 20239:48 amRNSHolding(s) in Company
13th Mar 20231:31 pmRNSDirector/PDMR Shareholding
13th Mar 202312:22 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNS2022 Full Year Results
8th Mar 20233:09 pmRNSChange of Director Details
21st Feb 202310:32 amRNSHolding(s) in Company
31st Jan 20239:30 amRNSBoard Changes
30th Jan 20236:04 pmRNSHolding(s) in Company
23rd Dec 202210:31 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSCompletion of the Acquisition of Durex Industries
17th Nov 20227:00 amRNSTrading Statement
27th Oct 20224:24 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSCompletion of the acquisition of Vulcanic
28th Sep 20227:00 amRNSAcquisition of US Thermal Energy Specialist
6th Sep 202212:41 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNS2022 Half Year Results
25th Jul 20227:30 amRNSVulcanic Acquisition Agreement Executed
4th Jul 202211:04 amRNSAmendment to 0126R - Director/PDMR Shareholding
4th Jul 20227:30 amRNSExclusive negotiations to acquire Vulcanic
1st Jul 202210:37 amRNSDirector/PDMR Shareholding
29th Jun 20227:00 amRNSInvestor Seminar
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
20th Jun 20227:00 amRNSDirector/PDMR Shareholding
23rd May 202210:48 amRNSElectric Thermal Solutions Business Update
23rd May 20229:08 amRNSDirector/PDMR Shareholding
11th May 20223:02 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Trading Update
19th Apr 20223:10 pmRNSDirector/PDMR Shareholding
14th Apr 202212:00 pmRNSChange of Director Details
21st Mar 202210:10 amRNSDirector/PDMR Shareholding
17th Mar 20228:30 amRNSDirector/PDMR Shareholding
15th Mar 20223:00 pmRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNS2021 Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.